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Dynorphin A and its fragments (e.g. dynorphin 
A-(1-13)) potently displace prototypical alkaloid 
ligands for the ~ subtype of opioid receptor in rat 
(Quirion and Pert, 1981) and guinea pig (Chavkin 
et al., 1982; Corbett et al., 1982) brain membranes. 
However, we and others (Quirion and Pert, 1981; 
Corbett et al., 1982) have found that dynorphin 
A-related peptides also exhibit substantial potency 
in displacing prototypical/~ and 6 receptor ligands 
from brain membranes. Since these ligands are not 
completely selective, it is difficult to distinguish 
whether dynorphin acts at the/~ and 8 sites or if 
the radioligands bind to the K receptor. This issue 
has been clarified for guinea pig brain: [3H]dy- 
norphin A binds specifically to guinea pig brain 
membranes and appears to selectively label x sites 
(Young et al., 1983). These sites, when labelled by 
[3H]ethylketocyclazocine or [3H]bremazocine, are 
concentrated in the deep layers of guinea pig 
cerebral cortex (Goodman and Snyder, 1982). Since 
these tritiated alkaloids exhibit little receptor selec- 
tivity, excess concentrations of ~ and ~ ligands are 
included in the incubation medium to ensure that 
only x sites are available for labelling (Corbett et 
al., 1982; Goodman and Snyder, 1982). However, 
the concentration of morphine (30 nM) used by 
Goodman and Snyder (1982) may have been insuf- 
ficient to saturate the /~ sites (cf. Corbett et al., 
1982). Since [3H]dynorphin A exhibits high x 
selectivity in guinea pig brain (Young et al., 1983), 
we carried out the present study to determine 
whether specific binding sites for this ligand are 
distributed in the deep cortical layers. 
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Adult male Hartley guinea pigs were deeply 
anesthetized with pentobarbital and their brains 
were rapidly removed and frozen. Twenty-/~m 
coronal sections of the brains were cut in a Bright 
cryostat at -16°C and thaw-mounted onto gela- 
tin-coated microscope slides. The sections were 
dried at 0°C under vacuum and stored at -70°C 
before being warmed to 4°C for assay. The sec- 
tions were covered with 200/~1 of 0.05 M Tris. HC1 
(pH 7.55) containing 2.5 nM [3H]dynorphin A for 
90 min at 4°C (Young et al., 1983). Nonspecific 
binding was evaluated by incubating adjacent sec- 
tions in the same medium also containing 10/~M 
UM-1071 (the active stereoisomer of MR 2034, a 
potent K agonist; see Young et al., 1983). The 
slides were then washed by continuous agitation in 
4 changes (2 rain each) of 200 ml of 0.05 M Tris 
HC1 (pH 7.55) at 4°C, rapidly dried under a 
stream of cool air, and exposed in an X-ray cas- 
sette to tritium-sensitive LKB Ultrofilm for 10 
weeks. The film was then developed for autoradi- 
ography according to the manufacturer's direc- 
tions, and photographed using an enlarger. 
[3H]Dynorphin A binding to guinea pig brain 
sections, as determined by liquid scintillation 
counting of the sections after agitation for 1 h in 
scintillant, was displaced approximately 45 percent 
by 10 FM UM-1071, a x ligand previously shown 
to specifically (and selectively) displace [3H]dy- 
norphin A binding in guinea pig brain membranes 
(Young et al., 1983). Autoradiographs of the sec- 
tions revealed a concentration of [3H]dynorphin A 
binding sites in the deeper layers (predominantly 
V and VI) of cerebral cortex (fig. 1A), although 
there were some regional variations in binding site 
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Fig. 1. Distribution of [3H]dynorphin A binding sites in a 
coronal section of guinea pig cerebral cortex (parietal region). 
Autoradiographs show binding in the absence (A) and presence 
(B) of 10/LM UM-1071, a potent ~ agonist. The concentration 
of [ 3 H]dynorphin A binding sites in the deeper layers is blocked 
by UM-1071, while the residual nonspecific binding is uni- 
formly distributed throughout the cortical laminae. 
density. The concentration of sites in the deeper 
cortical layers was not shown in sections exposed 
to 10 /~M UM-1071 (fig. 1B), demonstrating the 
specificity of this regional distribution of binding 
sites. 
The localization of specific [3H]dynorphin A 
binding sites in the deep layers of guinea pig 
cerebral cortex is consistent with previous reports 
that alkaloid-labelled r opioid receptors are simi- 
larly distributed (Goodman and Snyder, 1982) and 
that dynorphin A appears to be x-selective in 
guinea pig brain tissue (Chavkin et al., 1982; 
Corbett et al., 1983; Young et al., 1983). # and 8 
sites in contrast, appear to have a different locali- 
zation within guinea pig cerebral cortex (Good- 
man and Snyder, 1982). Parenthetically, we have 
found it difficult to obtain UM-1071-displaceable 
[3H]dynorphin A binding in rat brain sections, 
which may be consistent with the reported lack of 
K selectivity of dynorphin in rat brain (Quirion 
and Pert, 1981). 
The pharmacological significance of x receptors 
in the deep cortical layers of guinea pig brain is 
unknown. These receptors have been suggested to 
mediate the sedative effects of x alkaloids (Good- 
man and Snyder, 1982), an idea which requires 
experimental testing. The significance of cerebral 
cortical x opioid receptors may become clearer 
when their distribution is studied in relation to 
endogenous opioid neural pathways. 
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